Tag: cytomegalovirus

EU clears MSD’s Prevymis for CMV prevention

by Selina McKee | Jan 30, 2018 | News | 0

European regulators have approved MSD’s Prevymis for the prevention of cytomegalovirus (CMV) reactivation and disease in prone adults who have received an allogeneic haematopoietic stem cell transplant (HSCT).

Shire’s cytomegalovirus therapy wins ‘Breakthrough’ status

by Selina McKee | Jan 5, 2018 | News | 0

An experimental drug being developed by Shire to treat cytomegalovirus (CMV) infection has been given a boost in the US with a ‘Breakthrough Therapy Designation’.